Diabetes Treatment Denied in Indiana: Guide

Indiana has approximately 650,000 adults diagnosed with diabetes, and the state's insurance landscape — including commercial plans and the Healthy Indiana Plan (HIP) Medicaid — creates significant barriers to access for newer diabetes technologies and medications. If your Indiana insurer has denied insulin, a CGM, an insulin pump, or a GLP-1 drug like Ozempic or Mounjaro, you have specific rights under Indiana law to challenge that decision.

The Indiana Insurance Landscape for Diabetes

Major health insurers in Indiana include Anthem Blue Cross Blue Shield of Indiana, Cigna, UnitedHealthcare, MDwise (Managed Health Services), and Ambetter from MHS (Meridian Health Services). Indiana's insurance market is dominated by Anthem, which covers a large share of both commercial and Medicaid members in the state. The HealthCare.gov marketplace serves individual plan purchasers.

The Indiana Department of Insurance (IDOI) regulates fully insured health plans sold in Indiana. Self-funded employer plans are governed by federal ERISA. Indiana has some diabetes-specific coverage mandates, including requirements for insulin and diabetes supply coverage.

Indiana's Insulin Cost-Cap Law

Indiana enacted an insulin cost-cap law capping monthly insulin costs at $35 per 30-day supply for state-regulated insurance plans. This applies to individual and group plans regulated by the IDOI. Self-funded ERISA plans may not be subject to this state cap, but federal Medicare Part D protections provide a similar cap for Medicare beneficiaries.

Medicaid (Healthy Indiana Plan / HIP) and Diabetes

Indiana's Medicaid program for low-income adults operates through the Healthy Indiana Plan (HIP 2.0), which includes a unique POWER Account system (a health savings account component). Medicaid MCOs in Indiana include Anthem, MDwise, and MHS.

HIP covers insulin, oral diabetes medications, blood glucose monitoring supplies, and CGMs with Prior Authorization Denied: How to Appeal" class="auto-link">prior authorization. Insulin pumps are covered for eligible patients, typically requiring Type 1 diabetes or documented intensive insulin therapy failure. If your HIP plan denied diabetes treatment, file a grievance with your MCO. If unresolved, request a State Fair Hearing through the Indiana Family and Social Services Administration (FSSA) at 1-800-403-0864.

Common Denials in Indiana

GLP-1 Drugs (Ozempic, Mounjaro, Trulicity, Victoza): Anthem Blue Cross Indiana and other carriers impose prior authorization and step therapy for GLP-1 agonists. Indiana does not have as robust a step therapy exception law as some other states, so the appeal strategy focuses on demonstrating clinical failure of alternatives and documenting the specific clinical rationale for the GLP-1 drug. Emphasize the cardiovascular risk reduction benefits (LEADER trial, SUSTAIN trials) and the failure or contraindication of alternatives.

CGMs: Common denials occur for Type 2 patients not on prandial insulin. The ADA's 2024 Standards of Care explicitly recommend CGMs for patients using insulin, and your physician's letter should cite this. Document any hypoglycemia episodes as these are compelling evidence of medical necessity.

Insulin Pumps: Anthem's criteria for pump coverage require MDI failure documentation and a physician attestation from an endocrinologist. Without endocrinologist involvement, pump approvals are difficult to obtain in Indiana.

Specialist Access: Indiana has a shortage of endocrinologists in rural areas. If there is no in-network endocrinologist within a reasonable distance, request network adequacy accommodations from your plan.

How to Appeal a Diabetes Denial in Indiana

1. Request the written denial reason and clinical criteria used by your insurer.
2. Have your physician prepare a letter of medical necessity citing ADA Standards of Care, cardiovascular outcome trial data for GLP-1 drugs, and your documented clinical history.
3. File an internal appeal within 180 days of the denial. Indiana requires insurers to resolve standard appeals within 30 days and urgent appeals within 72 hours.
4. Request External Independent Review: Complete Guide" class="auto-link">external review through the Indiana Department of Insurance if the internal appeal fails. Indiana uses certified IROs for external review, which is free to patients and binding on the insurer.
5. File a complaint with the Indiana Department of Insurance at 1-800-622-4461 or in.gov/idoi.

For HIP/Medicaid fair hearings, contact FSSA at 1-800-403-0864.

State Insurance Department Contact

Indiana Department of Insurance (IDOI)

• Consumer Hotline: 1-800-622-4461
• Website: in.gov/idoi

Indiana Family and Social Services Administration (FSSA — Medicaid)

• Phone: 1-800-403-0864
• Website: in.gov/fssa

Additional Resources

The American Diabetes Association (diabetes.org) offers Indiana-specific advocacy resources and appeal templates. Indiana Legal Services (indianalegalservices.org) provides free legal assistance to low-income Hoosiers facing insurance coverage disputes, including Medicaid denials.

Indiana's external review system offers a real mechanism to challenge denials. With well-documented physician support and specific clinical citations, many external reviews result in coverage being granted for diabetes devices and medications that insurers initially refused.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• What Is Step Therapy?